C12Y 302/01096
Mannosyl-glycoprotein endo-beta-n-acetylglucosaminidase
Official title: Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase (3.2.1.96)
C12Y302/01096 (Mannosyl-glycoprotein endo-beta-n-acetylglucosaminidase) appears on 82 US grants and 132 published applications in this corpus.
Search patents in C12Y- Granted patents
- 82
- Published applications
- 132
- Assignees
- 70
- Inventors
- 272
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 2 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 3 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 1 | 6 |
| 2012 | 1 | 2 |
| 2013 | 2 | 7 |
| 2014 | 7 | 9 |
| 2015 | 2 | 8 |
| 2016 | 5 | 7 |
| 2017 | 8 | 7 |
| 2018 | 6 | 6 |
| 2019 | 5 | 14 |
| 2020 | 8 | 11 |
| 2021 | 9 | 8 |
| 2022 | 4 | 3 |
| 2023 | 6 | 5 |
| 2024 | 3 | 15 |
| 2025 | 3 | 5 |
| 2026 | 1 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetically engineered eukaryotic cells producing sialylated glycoproteins6 Jan 2026US 12,516,361 B2Universiteit Gent
- Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins16 Dec 2025US 12,497,643 B2University of Maryland, College Park
- Method for improving the benefit to a subject of a therapy or therapeutic agent26 Aug 2025US 12,397,044 B2Hansa Biopharma AB
- Cleaning compositions containing Dispersins III6 May 2025US 12,291,696 B2Henkel AG & Co. KGaA
- Fc glycan remodeling platform method for site-specific antibody conjugation and applications thereof12 Nov 2024US 12,139,509 B2University of Maryland, College Park
- Site-specific orthogonal bioconjugate modality and application thereof24 Sep 2026US 2026/0286332 A1Genequantum Healthcare (Suzhou) Co., Ltd.
- Method for immunologically measuring hemoglobin using deglycosylated haptoglobin13 Aug 2026US 2026/0235630 A1Eiken Kagaku Kabushiki Kaisha
- Glycosynthase variants for antibody-drug conjugate engineering6 Aug 2026US 2026/0224724 A1
- Novel endo-b-n-acetylglucosaminidases and their uses for the production of freed n-glycans from food30 Jul 2026US 2026/0218153 A1Board of Regents of the Nevada System of Higher Education On Behalf of the University of Nevada Ren
- Methods and systems for glycoprotein assays30 Apr 2026US 2026/0118365 A1Seer, Inc.
Most cited
By later US patents
- Method for preparing glycan-hydrolyzed antibody, and homogeneous glycosylated antibody64US 9,550,834 B2Immuno-Biological Laboratories Co., Ltd. · 2017
- Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof37US 9,434,786 B2University of Maryland, Baltimore · 2016
- Streptomyces secretion vector25US 4,745,056 ABiotechnica International, Inc. · 1988
- Fanout device for optical fibers of a multi-fiber cable19US 5,732,181 ATelefonaktiebolaget LM Ericsson · 1998
- Process for producing N-acetyl-D-glucosamine19US 5,998,173 AThe University of Bristish Columbia · 1999